Managing the risk of toxicity in the treatment of elderly patients with soft tissue sarcomas.

Nearly half of soft tissue sarcomas (STS) occur after the age of 65 years. Treating these patients is a complex issue in the absence of specific guidelines.This is a narrative review that summarize...